vs

Side-by-side financial comparison of CASELLA WASTE SYSTEMS INC (CWST) and Penumbra Inc (PEN). Click either name above to swap in a different company.

CASELLA WASTE SYSTEMS INC is the larger business by last-quarter revenue ($557.2M vs $385.4M, roughly 1.4× Penumbra Inc). Penumbra Inc runs the higher net margin — 12.3% vs -1.0%, a 13.3% gap on every dollar of revenue. On growth, Penumbra Inc posted the faster year-over-year revenue change (22.1% vs 9.6%). Penumbra Inc produced more free cash flow last quarter ($68.0M vs $30.7M). Over the past eight quarters, CASELLA WASTE SYSTEMS INC's revenue compounded faster (21.5% CAGR vs 17.6%).

Casella Waste Systems, Inc. is a waste management company based in Rutland, Vermont, United States. Founded in 1975 with a single truck, Casella is a regional, vertically integrated solid waste services company. Casella provides resource management expertise and services to residential, commercial, municipal and industrial customers, primarily in the areas of solid waste collection and disposal, transfer, recycling and organics services. The company provides integrated solid waste services in...

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

CWST vs PEN — Head-to-Head

Bigger by revenue
CWST
CWST
1.4× larger
CWST
$557.2M
$385.4M
PEN
Growing faster (revenue YoY)
PEN
PEN
+12.5% gap
PEN
22.1%
9.6%
CWST
Higher net margin
PEN
PEN
13.3% more per $
PEN
12.3%
-1.0%
CWST
More free cash flow
PEN
PEN
$37.4M more FCF
PEN
$68.0M
$30.7M
CWST
Faster 2-yr revenue CAGR
CWST
CWST
Annualised
CWST
21.5%
17.6%
PEN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CWST
CWST
PEN
PEN
Revenue
$557.2M
$385.4M
Net Profit
$-5.5M
$47.3M
Gross Margin
68.0%
Operating Margin
0.9%
15.4%
Net Margin
-1.0%
12.3%
Revenue YoY
9.6%
22.1%
Net Profit YoY
-15.2%
40.6%
EPS (diluted)
$-0.09
$1.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CWST
CWST
PEN
PEN
Q1 26
$557.2M
Q4 25
$469.1M
$385.4M
Q3 25
$485.4M
$354.7M
Q2 25
$465.3M
$339.5M
Q1 25
$417.1M
$324.1M
Q4 24
$427.5M
$315.5M
Q3 24
$411.6M
$301.0M
Q2 24
$377.2M
$299.4M
Net Profit
CWST
CWST
PEN
PEN
Q1 26
$-5.5M
Q4 25
$-2.5M
$47.3M
Q3 25
$10.0M
$45.9M
Q2 25
$5.2M
$45.3M
Q1 25
$-4.8M
$39.2M
Q4 24
$4.9M
$33.7M
Q3 24
$5.8M
$29.5M
Q2 24
$7.0M
$-60.2M
Gross Margin
CWST
CWST
PEN
PEN
Q1 26
Q4 25
33.3%
68.0%
Q3 25
35.0%
67.8%
Q2 25
33.8%
66.0%
Q1 25
32.8%
66.6%
Q4 24
33.2%
66.8%
Q3 24
35.1%
66.5%
Q2 24
35.4%
54.4%
Operating Margin
CWST
CWST
PEN
PEN
Q1 26
0.9%
Q4 25
2.5%
15.4%
Q3 25
6.1%
13.8%
Q2 25
4.1%
12.0%
Q1 25
0.8%
12.4%
Q4 24
4.3%
13.6%
Q3 24
5.9%
11.7%
Q2 24
6.1%
-27.0%
Net Margin
CWST
CWST
PEN
PEN
Q1 26
-1.0%
Q4 25
-0.5%
12.3%
Q3 25
2.1%
12.9%
Q2 25
1.1%
13.3%
Q1 25
-1.2%
12.1%
Q4 24
1.1%
10.7%
Q3 24
1.4%
9.8%
Q2 24
1.9%
-20.1%
EPS (diluted)
CWST
CWST
PEN
PEN
Q1 26
$-0.09
Q4 25
$-0.04
$1.20
Q3 25
$0.16
$1.17
Q2 25
$0.08
$1.15
Q1 25
$-0.08
$1.00
Q4 24
$0.08
$0.88
Q3 24
$0.10
$0.75
Q2 24
$0.12
$-1.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CWST
CWST
PEN
PEN
Cash + ST InvestmentsLiquidity on hand
$126.9M
$186.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
$1.4B
Total Assets
$3.3B
$1.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CWST
CWST
PEN
PEN
Q1 26
$126.9M
Q4 25
$123.8M
$186.9M
Q3 25
$192.7M
$321.0M
Q2 25
$217.8M
$421.8M
Q1 25
$267.7M
$376.1M
Q4 24
$358.3M
$324.4M
Q3 24
$519.0M
$280.5M
Q2 24
$208.5M
$288.3M
Total Debt
CWST
CWST
PEN
PEN
Q1 26
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$1.0B
Q2 24
$976.6M
Stockholders' Equity
CWST
CWST
PEN
PEN
Q1 26
$1.6B
Q4 25
$1.6B
$1.4B
Q3 25
$1.6B
$1.4B
Q2 25
$1.6B
$1.3B
Q1 25
$1.5B
$1.2B
Q4 24
$1.6B
$1.2B
Q3 24
$1.5B
$1.1B
Q2 24
$1.0B
$1.2B
Total Assets
CWST
CWST
PEN
PEN
Q1 26
$3.3B
Q4 25
$3.3B
$1.8B
Q3 25
$3.3B
$1.7B
Q2 25
$3.3B
$1.7B
Q1 25
$3.2B
$1.6B
Q4 24
$3.2B
$1.5B
Q3 24
$3.1B
$1.5B
Q2 24
$2.5B
$1.5B
Debt / Equity
CWST
CWST
PEN
PEN
Q1 26
Q4 25
0.72×
Q3 25
0.72×
Q2 25
0.72×
Q1 25
0.72×
Q4 24
0.70×
Q3 24
0.68×
Q2 24
0.94×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CWST
CWST
PEN
PEN
Operating Cash FlowLast quarter
$62.3M
$86.5M
Free Cash FlowOCF − Capex
$30.7M
$68.0M
FCF MarginFCF / Revenue
5.5%
17.7%
Capex IntensityCapex / Revenue
9.0%
4.8%
Cash ConversionOCF / Net Profit
1.83×
TTM Free Cash FlowTrailing 4 quarters
$120.7M
$174.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CWST
CWST
PEN
PEN
Q1 26
$62.3M
Q4 25
$96.6M
$86.5M
Q3 25
$93.6M
$58.3M
Q2 25
$89.5M
$44.9M
Q1 25
$50.1M
$49.0M
Q4 24
$109.8M
$51.1M
Q3 24
$91.8M
$56.5M
Q2 24
$72.1M
$22.6M
Free Cash Flow
CWST
CWST
PEN
PEN
Q1 26
$30.7M
Q4 25
$39.3M
$68.0M
Q3 25
$27.6M
$42.0M
Q2 25
$23.1M
$29.4M
Q1 25
$-5.4M
$35.5M
Q4 24
$32.9M
$45.7M
Q3 24
$40.4M
$51.0M
Q2 24
$27.5M
$18.1M
FCF Margin
CWST
CWST
PEN
PEN
Q1 26
5.5%
Q4 25
8.4%
17.7%
Q3 25
5.7%
11.8%
Q2 25
5.0%
8.7%
Q1 25
-1.3%
11.0%
Q4 24
7.7%
14.5%
Q3 24
9.8%
16.9%
Q2 24
7.3%
6.0%
Capex Intensity
CWST
CWST
PEN
PEN
Q1 26
9.0%
Q4 25
12.2%
4.8%
Q3 25
13.6%
4.6%
Q2 25
14.3%
4.6%
Q1 25
13.3%
4.2%
Q4 24
18.0%
1.7%
Q3 24
12.5%
1.8%
Q2 24
11.8%
1.5%
Cash Conversion
CWST
CWST
PEN
PEN
Q1 26
Q4 25
1.83×
Q3 25
9.37×
1.27×
Q2 25
17.19×
0.99×
Q1 25
1.25×
Q4 24
22.51×
1.52×
Q3 24
15.91×
1.91×
Q2 24
10.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CWST
CWST

Collection$334.8M60%
Transfer station$65.9M12%
Processing (ii)$49.0M9%
Landfill$48.0M9%
National Accounts (ii)$45.6M8%
Transportation$8.2M1%
Landfill gas-to-energy$2.9M1%

PEN
PEN

Thrombectomy$254.7M66%
Other$130.7M34%

Related Comparisons